Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3811480 | 0.98 | ALDH1A1 (0.30) | ALDH1A1LMNA | |
| SCHEMBL7630825 | 0.80 | LMNA (0.31) | LMNA | |
| SCHEMBL5088233 | 0.79 | — | — | |
| SCHEMBL16393781 | 0.79 | USP2 (0.32) | — | |
| SCHEMBL7055976 | 0.79 | CYP11B1 (0.33) | ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL6860527 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL6858492 | 0.78 | ALDH1A1 (0.30) | ALDH1A1LMNA | |
| SCHEMBL7567494 | 0.78 | LMNA (0.34) | LMNA | |
| Hydrochloric Acid SCHEMBL6862648 | 0.78 | ALDH1A1 (0.30) | ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL6860531 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0889911-B1 | METALLOCENE COCATALYST | DOW CHEMICAL CO (US) | 2000-11-02 | — | — | EP | claimed |
| EP-0891381-B2 | OLEFIN SOLUTION POLYMERIZATION | DOW CHEMICAL CO (US) | 2006-05-24 | — | — | EP | disclosed |
| EP-0980375-B1 | N-SILYLATED COMPOUND SYNTHESIS | BOULDER SCIENT CO (US) | 2005-11-09 | — | — | EP | disclosed |
| EP-0980375-A4 | SILYLATED AND N-SILYLATED COMPOUND SYNTHESIS | BOULDER SCIENT CO (US) | 2003-01-22 | — | — | EP | disclosed |
| EP-0874860-B1 | SUBSTITUTED INDENYL CONTAINING METAL COMPLEXES AND OLEFIN POLYMERIZATION PROCESS | DOW CHEMICAL CO (US) | 2002-11-13 | — | — | EP | disclosed |
| US-6410767-B2 | USING N-SILYLATED MONO(CYCLOPENTADIENYL) LIGAND | BOULDER SCIENTIFIC CO. | 2002-06-25 | — | — | US | disclosed |
| US-20010056199-A1 | Silylated and N-silylated compound synthesis | BOULDER SCIENTIFIC COMPANY | 2001-12-27 | — | — | US | disclosed |
| EP-0891381-B1 | OLEFIN SOLUTION POLYMERIZATION | DOW CHEMICAL CO (US) | 2001-12-12 | — | — | EP | disclosed |
| US-6180810-B1 | SILYL AMINES WHICH BOND COVALENTLY TO METAL CENTER OF COMPLEX TO PROVIDE OLEFIN POLYMERIZATION CATALYST COMPONENT | BOULDER SCIENTIFIC COMPANY | 2001-01-30 | — | — | US | disclosed |
| US-6087518-A | Silylated and N-silylated compound synthesis | BOULDER SCIENTIFIC COMPANY (US) | 2000-07-11 | — | — | US | disclosed |
| EP-0980375-A1 | N-SILYLATED COMPOUND SYNTHESIS | BOULDER SCIENTIFIC COMPANY (US) | 2000-02-23 | — | — | EP | disclosed |
| US-6015868-A | CATALYSIS OF HIGH TEMPERATURE, SOLUTION POLYMERIZATION WHICH YIELDS HIGH MOLECULAR WEIGHT OLEFIN POLYMERS, BY USING COORDINATION CATALYST MIXED WITH AN ACTIVATING COCATALYST, EFFICIENCY | THE DOW CHEMICAL COMPANY (US) | 2000-01-18 | — | — | US | disclosed |
| WO-1999038871-A1 | SILYLATED AND N-SILYLATED COMPOUND SYNTHESIS | BOULDER SCIENTIFIC COMPANY (US) | 1999-08-05 | — | — | WO | disclosed |
| EP-0563365-A1 | PREPARATION OF METAL COORDINATION COMPLEX | THE DOW CHEMICAL COMPANY (US) | 1993-10-06 | — | — | EP | disclosed |
| WO-1993008199-A1 | PREPARATION OF METAL COORDINATION COMPLEX | THE DOW CHEMICAL COMPANY (US) | 1993-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010056199-A1 | Silylated and N-silylated compound synthesis | LSS, NCL, FNTA | ALDH1A1 2906/4885LMNA 1087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.